Lorinda Soma

CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Journal of Clinical Investigation · 2016 · 2.1K citations · Full text

Medicine, Immunology, Oncology +17

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 ⁺ and CD4 ⁺ CD19-specific chimeric antigen receptor–modified T cells

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Science Translational Medicine · 2016 · 1K citations

Medicine, Immunology, Oncology +17

The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma

Lorinda Soma, Fiona E. Craig, Steven H. Swerdlow · Human Pathology · 2006 · 86 citations

Veterinary Medicine, Cell Biology, Oncology +16

Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes

Cameron J. Turtle, Carolina Berger, Daniel Sommermeyer et al. · Blood · 2015 · 70 citations

Life Sciences, Hematology, Oncology +17

Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Blood · 2015 · 56 citations

Medicine, Hematology, Immunology +17